Deutsche Bank
CSBR icon

Deutsche Bank’s Champions Oncology CSBR Stock Holding History

Deutsche Bank’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,129
Closed -$47K – 4633
2021
Q1 		$47K Sell
4,129
-399
-9% -$4.63K ﹤0.01% 4249
2020
Q4 		$49K Buy
4,528
+855
+23% +$8.82K ﹤0.01% 4114
2020
Q3 		$34K Buy
3,673
+352
+11% +$3.13K ﹤0.01% 4015
2020
Q2 		$32K Buy
+3,321
New +$28.3K ﹤0.01% 3971
2019
Q1 		– Sell
-10,100
Closed -$78K – 5211
2018
Q4 		$78K Sell
10,100
-65,147
-87% -$748K ﹤0.01% 4315
2018
Q3 		$1.31M Buy
75,247
+58,147
+340% +$518K ﹤0.01% 3118
2018
Q2 		$108K Buy
+17,100
New +$82.2K ﹤0.01% 4519
2018
Q1 		– Sell
-15,395
Closed -$59K – 5428
2017
Q4 		$59K Sell
15,395
-2,805
-15% -$10K ﹤0.01% 4395
2017
Q3 		$66K Buy
+18,200
New +$55.7K ﹤0.01% 4293
2017
Q2 		– Sell
-841
Closed -$2K – 4959
2017
Q1 		$2K Buy
+841
New +$2.94K ﹤0.01% 4771

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Deutsche Bank's CSBR Position: Q2 2021 in Review

Deutsche Bank sold out of Champions Oncology (CSBR) in Q2 2021, closing a stake of 4,129 shares — an estimated $47K sold.

Deutsche Bank first reported a position in CSBR in Q1 2017 and held it in 10 quarters. The position peaked at $1.31M in Q3 2018. 38 funds tracked by Wall St. Rank hold CSBR as of Q2 2021.

  • Deutsche Bank reported no remaining Champions Oncology position as of Q2 2021 after selling out during the quarter.
  • Deutsche Bank sold 4,129 Champions Oncology shares in Q2 2021, an estimated $47K.
  • Deutsche Bank first reported a position in Champions Oncology in Q1 2017 and held it in 10 quarters.
  • Deutsche Bank's Champions Oncology position peaked at $1.31M in Q3 2018.
  • 38 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2021.

Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.